JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors
Clinical trial NCT07475559 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07475559
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2028-07-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.